Establishing and augmenting views on the acceptability of a paediatric critical care randomised controlled trial (the FEVER trial): a mixed methods study.

medical education & training paediatric intensive & critical care paediatrics pain management qualitative research

Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
10 03 2021
Historique:
entrez: 11 3 2021
pubmed: 12 3 2021
medline: 20 5 2021
Statut: epublish

Résumé

To explore parent and staff views on the acceptability of a randomised controlled trial investigating temperature thresholds for antipyretic intervention in critically ill children with fever and infection (the FEVER trial) during a multi-phase pilot study. Mixed methods study with data collected at three time points: (1) before, (2) during and (3) after a pilot trial. English, Paediatric Intensive Care Units (PICUs). (1) Pre-pilot trial focus groups with pilot site staff (n=56) and interviews with parents (n=25) whose child had been admitted to PICU in the last 3 years with a fever and suspected infection, (2) Questionnaires with parents of randomised children following pilot trial recruitment (n=48 from 47 families) and (3) post-pilot trial interviews with parents (n=19), focus groups (n=50) and a survey (n=48) with site staff. Analysis drew on Sekhon There was initial support for the trial, yet some held concerns regarding the proposed temperature thresholds and not using paracetamol for pain or discomfort. Pre-trial findings informed protocol changes and training, which influenced views on trial acceptability. Staff trained by the FEVER team found the trial more acceptable than those trained by colleagues. Parents and staff found the trial acceptable. Some concerns about pain or discomfort during weaning from ventilation remained. Pre-trial findings and pilot trial experience influenced acceptability, providing insight into how challenges may be overcome. We present an adapted theoretical framework of acceptability to inform future trial feasibility studies. ISRCTN16022198 and NCT03028818.

Identifiants

pubmed: 33692177
pii: bmjopen-2020-041952
doi: 10.1136/bmjopen-2020-041952
pmc: PMC7949453
doi:

Substances chimiques

Antipyretics 0

Banques de données

ClinicalTrials.gov
['NCT03028818']
ISRCTN
['ISRCTN16022198']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e041952

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: MJP is a member of the NIHR HTA Board. KMR is a member of the NIHR HS & DR Board.

Références

Crit Care. 2019 Mar 7;23(1):69
pubmed: 30845977
Health Technol Assess. 2018 Sep;22(51):1-106
pubmed: 30238870
Lancet. 2004 Aug 28-Sep 3;364(9436):803-11
pubmed: 15337409
Clin Dermatol. 2017 Nov - Dec;35(6):583-593
pubmed: 29191349
Trials. 2006 Dec 12;7:32
pubmed: 17163988
BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
BMJ Open. 2015 Sep 18;5(9):e008522
pubmed: 26384724
J Pediatr. 2002 Dec;141(6):798-803
pubmed: 12461496
Eur J Pediatr. 2017 Mar;176(3):423-427
pubmed: 28097438
BMC Health Serv Res. 2017 Jan 26;17(1):88
pubmed: 28126032
Arch Dis Child. 2019 Nov;104(11):1077-1082
pubmed: 31175125
Int J Qual Stud Health Well-being. 2014 Oct 16;9:26152
pubmed: 25326092
Health Technol Assess. 2014 Jun;18(38):1-197, v-vi
pubmed: 24914457
BMC Public Health. 2013 Aug 15;13:756
pubmed: 23947336
Contemp Clin Trials Commun. 2017 Nov 23;9:33-39
pubmed: 29696222
Arch Dis Child. 2019 Oct;104(10):979-983
pubmed: 31175126
Milbank Q. 2001;79(4):613-39, v
pubmed: 11789119
Health Technol Assess. 2019 Feb;23(5):1-148
pubmed: 30793698
Trials. 2014 Oct 16;15:399
pubmed: 25322807
J Med Ethics. 2011 Jul;37(7):429-32
pubmed: 21345861
PLoS One. 2013;8(2):e54894
pubmed: 23408950
Arch Dis Child Educ Pract Ed. 2016 Feb;101(1):49-53
pubmed: 26464416
Qual Quant. 2018;52(4):1893-1907
pubmed: 29937585
Arch Dis Child. 2019 May;104(5):426-431
pubmed: 30087153
BMJ Open. 2018 Jun 9;8(6):e022894
pubmed: 29886449
Trials. 2006 Apr 07;7:9
pubmed: 16603070
Cochrane Database Syst Rev. 2010 Jan 20;(1):MR000013
pubmed: 20091668

Auteurs

Elizabeth Deja (E)

Public Health, Policy and Systems, University of Liverpool, Liverpool, UK e.deja@liverpool.ac.uk.

Mark J Peters (MJ)

Paediatric Intensive Care Unit, Great Ormond Street Hospital for Children NHS Trust, London, UK.
Infection, Immunity and Inflammation, Institute of Child Health, University College London, London, UK.

Imran Khan (I)

Institute of Population Health Sciences, Queen Mary University of London, London, UK.

Paul R Mouncey (PR)

Clinical Trials Unit, Intensive Care National Audit and Research Centre, London, UK.

Rachel Agbeko (R)

Paediatric Intensive Care Unit, Great North Children's Hospital, Newcastle Upon Tyne, UK.

Blaise Fenn (B)

Patient partner, London, UK.

Jason Watkins (J)

Patient partner, London, UK.

Padmanabhan Ramnarayan (P)

Children's Acute Transport Service, Great Ormond Street Hospital for Children, London, UK.

Shane M Tibby (SM)

Paediatric Intensive Care Unit, Evelina London Children's Hospital, London, UK.

Kentigern Thorburn (K)

Paediatric Intensive Care Unit, Alder Hey Children's Hospital, Liverpool, UK.

Lyvonne N Tume (LN)

School of Health and Society, University of Salford, Salford, UK.

Kathryn M Rowan (KM)

Intensive Care National Audit and Research Centre, London, UK.

Kerry Woolfall (K)

Public Health, Policy and Systems, University of Liverpool, Liverpool, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH